People: Covance Inc (CVD.N)

CVD.N on New York Stock Exchange

82.46USD
29 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$82.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
78,444
52-wk High
$106.49
52-wk Low
$73.58

Search Stocks

Summary

Name Age Since Current Position

Joseph Herring

58 2006 Chairman of the Board, Chief Executive Officer

Alison Cornell

51 2012 Chief Financial Officer, Vice President

Richard Cimino

54 2010 Executive Vice President, Group President - Clinical Development

Deborah Keller Tanner

51 2010 Executive Vice President, Group President - Research and Development Laboratories

William Klitgaard

60 2012 Corporate Senior Vice President, Chief Information Officer

James Lovett

49 2003 Corporate Senior Vice President, General Counsel, Secretary

John Watson

54 2010 Corporate Senior Vice President, Chief Commercial Officer, President - Strategic Partnering

Brian Nutt

44 2014 Principal Accounting Officer, Senior Director of External Reporting

Gary Costley

70 2007 Lead Independent Director

Robert Barchi

67 2003 Independent Director

Sandra Helton

64 2003 Independent Director

John McCartney

61 2009 Independent Director

Joseph Scodari

2008 Independent Director

Bradley Sheares

57 2009 Independent Director

Biographies

Name Description

Joseph Herring

Mr. Joseph L. Herring is Chairman of the Board, Chief Executive Officer of Covance Inc. He has been Covance's Chief Executive Officer since January 2005, and Chairman since January 2006. Mr. Herring was President and Chief Operating Officer from November 2001 to December 2004, and was Covance's Corporate Senior Vice President and President—Early Development Services from 1999 to November 2001. From September 1996 to September 1999, Mr. Herring was Corporate Vice President and General Manager of Covance Laboratories North America. Prior to joining Covance, Mr. Herring spent 18 years at the American Hospital Supply/Baxter International/Caremark International of healthcare service companies where he held of senior leadership positions, culminating in the position of Vice President and General Manager of its oncology business.

Alison Cornell

Ms. Alison Cornell is Chief Financial Officer, Vice President of Covance Inc. Ms. Cornell was Vice President, Global Financial Planning and Analysis from March 2009 to May 7, 2012. Ms. Cornell joined Covance in August 2004 as Vice President, Late Stage Development Services. Prior to joining Covance, Ms. Cornell spent 19 years at AT&T where she held a variety of senior leadership positions. Ms. Cornell has an MBA from Rutgers University, where she also attained her undergraduate degree. In addition, she is a Certified Treasury Professional (CTP) and completed the Program for Management Development at Harvard Business School.

Richard Cimino

Mr. Richard F. Cimino is Executive Vice President, Group President - Clinical Development of Covance Inc. From December 2004 through October 2010, Mr. Cimino was Corporate Senior Vice President and President—Clinical Development. Prior to that, Mr. Cimino was Covance's General Manager of Cardiac Safety Services commencing December 2003. Prior to that, Mr. Cimino was General Manager, America's Health Imaging Group and Corporate Vice President of Eastman Kodak Company.

Deborah Keller Tanner

Ms. Deborah L. Keller Tanner is Executive Vice President, Group President - Research and Development Laboratories of Covance Inc., November 2010. Ms. Keller Tanner was Corporate Senior Vice President and President—Global Central Laboratory Services from February 2006 through October 2010. Prior to that Ms. Keller Tanner was Covance's Global Vice President of Operations in Central Laboratory Services commencing in August 2001 and prior to that, Vice President—Analytical Services for Covance Laboratories—Europe. Ms. Keller Tanner has been with Covance for 25 years in positions of increasing responsibility.

William Klitgaard

Mr. William E. Klitgaard is Corporate Senior Vice President, Chief Information Officer of Covance Inc. Prior to that, Mr. Klitgaard was Covance's Corporate Senior Vice President, Chief Financial Officer and Treasurer since September 2000. From September 1999 to September 2000, Mr. Klitgaard was Covance's Corporate Vice President, Strategy and Corporate Development and Treasurer. From October 1996 to September 1999, Mr. Klitgaard was Covance's Corporate Vice President and Treasurer. Prior to that, Mr. Klitgaard was Treasurer at Kenetech Corporation in San Francisco, before which, Mr. Klitgaard had spent eleven years in positions of increasing responsibility with Consolidated Freightways Inc.

James Lovett

Mr. James W. Lovett, Esq., is Corporate Senior Vice President, General Counsel, Secretary of Covance Inc. He has headed Covance's Nutritional Chemistry and Food Safety Services since January 2008 and has led Covance's Market Access Services since November 2010. From December 2001 to February 2003, Mr. Lovett was Corporate Vice President, General Counsel and Secretary of Covance. From 1997 to 2001, Mr. Lovett was with FMC Corporation in positions of increasing responsibility and, prior to that, was a partner in the law firm of McDermott, Will & Emery.

John Watson

Mr. John E. Watson is Corporate Senior Vice President, Chief Commercial Officer, President - Strategic Partnering of Covance Inc. Mr. Watson was Corporate Vice President and President—Strategic Partnering & Integrated Drug Development from January 2009 to November 2010. Prior to that, Mr. Watson was Covance's Vice President of Corporate Marketing & Sales. Mr. Watson has been with Covance in positions of increasing responsibility beginning in February 1999. Prior to joining Covance, Mr. Watson spent 12 years in roles of increasing responsibility within the Bristol-Myers Squibb companies.

Brian Nutt

Mr. Brian H. Nutt is Principal Accounting Officer, Senior Director of External Reporting of Covance Inc. He had been Principal Accounting Officer and Director of External Reporting since May 2011. Mr. Nutt was Director, Corporate Finance from 2010 to 2011. Prior to that, Mr. Nutt was a Senior Manager, Corporate Finance. Prior to joining Covance in 2006, Mr. Nutt held positions of increasing responsibility at a number of companies including MedPointe Pharmaceuticals, Carter-Wallace and KPMG.

Gary Costley

Dr. Gary E. Costley, Ph.D., is Lead Independent Director of Covance Inc. He is a co-founder and managing director of C&G Capital and Management, LLC, which provides capital and management to health, medical and nutritional products and services companies. He was Chairman and Chief Executive Officer of International Multifoods Corporation, a manufacturer and marketer of branded consumer food and food service products from November 2001 until June 2004, and Chairman, President and Chief Executive Officer from 1997 through 2001. Dr. Costley is also a Director of The Principal Financial Group, a global financial institution, Tiffany & Co., a jewelry company, and Prestige Brand Holdings, Inc., a consumer products company. Dr. Costley has been a member of the Covance Board since September 2007.

Robert Barchi

Dr. Robert L. Barchi, M.D., Ph.D., is Independent Director of Covance Inc. He has been President of Rutgers University since September 2012. Prior to that, Dr. Barchi was President of Thomas Jefferson University commencing in September 2004. Prior to that, Dr. Barchi was Provost of the University of Pennsylvania since 1999. Previously, he served as Chair of the University of Pennsylvania's Department of Neurology and as founding Chair of the University's Department of Neuroscience. Dr. Barchi was also Director of the Mahoney Institute of Neurological Sciences for more than 12 years and was the Director of the Dana Fellowship Program in Neuroscience and Director of the Clinical Neuroscience Track. He was the founder and President of Penn Neurocare, a regional specialty network. Dr. Barchi has been a member of the Covance Board since October 2003.

Sandra Helton

Ms. Sandra L. Helton is Independent Director of Covance Inc. She was Executive Vice President and Chief Financial Officer of Telephone & Data Systems, Inc., a telecommunications service company, ("TDS") from October 2000 through December 2006. She joined TDS as Executive Vice President—Finance and Chief Financial Officer in August 1998. Prior to joining TDS, Ms. Helton was the Vice President and Corporate Controller of Compaq Computer Corporation between 1997 and 1998. Prior to that time, Ms. Helton was employed by Corning Incorporated. At Corning, Ms. Helton was Senior Vice President and Treasurer between 1994 and 1997 and was Vice President and Treasurer between 1991 and 1994. Ms. Helton is also a Director of The Principal Financial Group, a global financial institution, and Lexmark International, Inc., a printing and imaging solutions company. Ms. Helton has been a member of the Covance Board since September 2003.

John McCartney

Mr. John F. McCartney is Independent Director of Covance Inc. He has been Chairman of Huron Consulting Group Inc., a healthcare and educational consulting company since May 2010 and a director since October 2004. Mr. McCartney served as Chairman of A.M. Castle & Co., a specialty metals and plastics distributor from May 2007 to May 2010 and remains on its Board of Directors. Mr. McCartney serves as the Chairman of Westcon Group, Inc., a specialty distributor of networking and communications equipment since March 2011 and has served on its Board of Directors since 1998. Mr. McCartney was the Vice-Chairman of Datatec Limited, a technology holding company, from 1998 to 2004, and currently serves on its Board of Directors. Mr. McCartney was formerly President and Chief Operating Officer of U.S. Robotics. Mr. McCartney also served on the Board of Federal Signal Corporation, an environmental, safety and transportation solutions company, until April 2010. Mr. McCartney has been a member of the Covance Board since May 2009.

Joseph Scodari

Mr. Joseph C. Scodari is Independent Director of Covance Inc. He was Worldwide Chairman, Pharmaceuticals Group, of Johnson & Johnson, a diversified healthcare company, ("J&J") and a member of J&J's Executive Committee from March 2005 until March 2008. From 2003 to March 2005, Mr. Scodari was Company Group Chairman of J&J's Biopharmaceutical Business. Mr. Scodari joined J&J in 1999 as President and Chief Operating Officer of Centocor Inc., when J&J acquired the company. Mr. Scodari was a Director of Actelion Pharmaceuticals, Ltd., a pharmaceuticals company until May 2011. Mr. Scodari is a Director of Endo Health Solutions, Inc., a diversified healthcare company. Mr. Scodari has been a member of the Covance Board since May 2008.

Bradley Sheares

Dr. Bradley T. Sheares, Ph.D., is Independent Director of Covance Inc. He served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., a pharmaceutical company with integrated sales, marketing and development experience that marketed a portfolio of branded cardiovascular pharmaceutical products, from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health, Merck & Co., Inc. from March 2001 until July 2006. Prior to that time, he served as Vice President, Hospital Marketing and Sales for Merck's U.S. Human Health business. Dr. Sheares joined Merck in 1987 as a research fellow in the Merck Research Laboratories and held a wide range of positions within Merck, in business development, sales, and marketing, before becoming Vice President in 1996. Dr. Sheares is also a Director of The Progressive Corporation, an insurance and related services company, Honeywell International, Inc., a diversified technology and manufacturing company, and Henry Schein, Inc., a healthcare products and services company. Dr. Sheares was a director of IMS Health, a healthcare services company, until February 2010. Dr. Sheares has been a member of the Covance Board since February 2009.

Basic Compensation

Name Fiscal Year Total

Joseph Herring

8,965,100

Alison Cornell

2,525,650

Richard Cimino

1,769,470

Deborah Keller Tanner

1,814,220

William Klitgaard

1,866,900

James Lovett

1,616,250

John Watson

2,341,190

Brian Nutt

--

Gary Costley

--

Robert Barchi

--

Sandra Helton

--

John McCartney

--

Joseph Scodari

--

Bradley Sheares

--
As Of 30 Dec 2013

Options Compensation

Name Options Value

Joseph Herring

407,346 12,946,045

Alison Cornell

0 0

Richard Cimino

6,000 270,337

Deborah Keller Tanner

14,700 391,868

William Klitgaard

135,553 3,695,288

James Lovett

56,552 1,227,343

John Watson

0 0

Brian Nutt

0 0

Gary Costley

0 0

Robert Barchi

0 0

Sandra Helton

0 0

John McCartney

0 0

Joseph Scodari

0 0

Bradley Sheares

0 0
Search Stocks